We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $175M Turnover 50%
1-Year Est. Return 28.78%
This Fund
S&P 500
This Quarter Est. Return
+10.73%
1 Year Est. Return
+28.78%
3 Year Est. Return
+83.83%
5 Year Est. Return
+114.48%
10 Year Est. Return
+719.21%
AUM
$175M
AUM Growth
+$43.4M
Cap. Flow
+$23.3M
Cap. Flow %
13.29%
Top 10 Hldgs %
46.25%
Holding
46
New
12
Increased
14
Reduced
5
Closed
11
Avg Time Held Equity + Options
1.8 years
Top 10 Avg Time Held Equity + Options
0.4 years
Top 20 Avg Time Held Equity + Options
0.8 years
Avg Time Held Equity only
1.8 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
1 year

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$5.22M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$4.74M
3
MDT icon
Medtronic
MDT
+$3.97M
4
BRKR icon
Bruker
BRKR
+$3.83M
5
CI icon
Cigna
CI
+$3.72M

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$4.15M
2
AZN icon
AstraZeneca
AZN
+$3.94M
3
BSX icon
Boston Scientific
BSX
+$3.89M
4
THC icon
Tenet Healthcare
THC
+$3.77M
5
SYK icon
Stryker
SYK
+$3.29M

Sector Composition

Rank Sector Weight
1 Healthcare 83.79%
2 Miscellaneous 16.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
XBI icon
1
State Street SPDR S&P Biotech ETF
XBI
$9.9B
$28.4M 16.21%
180,000
+30,000
+20% +$4.74M
2024 Q3
8 quarters
HUM icon
2
Humana
HUM
$55.4B
$6.75M 3.86%
17,700
-2,300
-12% -$894K
2013 Q4
51 quarters
JNJ icon
3
Johnson & Johnson
JNJ
$680B
$6.35M 3.63%
24,000
+4,000
+20% +$1.06M
2026 Q1
2 quarters
MRK icon
4
Merck
MRK
$356B
$5.81M 3.32%
40,000
– –
2025 Q4
3 quarters
ABBV icon
5
AbbVie
ABBV
$521B
$5.75M 3.29%
22,000
+7,000
+47% +$1.79M
2025 Q3
4 quarters
TMO icon
6
Thermo Fisher Scientific
TMO
$256B
$5.74M 3.28%
8,500
+500
+6% +$297K
2025 Q3
4 quarters
CAH icon
7
Cardinal Health
CAH
$65.6B
$5.56M 3.18%
25,000
+1,000
+4% +$233K
2021 Q4
19 quarters
MCK icon
8
McKesson
MCK
$128B
$5.55M 3.17%
6,500
+2,500
+63% +$2.15M
2020 Q1
26 quarters
DHR icon
9
Danaher
DHR
$162B
$5.54M 3.16%
25,000
+5,000
+25% +$1.03M
2018 Q4
31 quarters
UNH icon
10
UnitedHealth
UNH
$369B
$5.51M 3.15%
15,000
+5,000
+50% +$2.01M
2024 Q4
7 quarters
VRTX icon
11
Vertex Pharmaceuticals
VRTX
$136B
$5.49M 3.14%
10,500
+500
+5% +$256K
2025 Q3
4 quarters
ELV icon
12
Elevance Health
ELV
$96.4B
$5.44M 3.11%
14,000
+9,000
+180% +$3.59M
2026 Q1
2 quarters
ABT icon
13
Abbott
ABT
$186B
$5.44M 3.11%
55,000
+30,000
+120% +$3.13M
2024 Q3
8 quarters
COR icon
14
Cencora
COR
$68.1B
$5.4M 3.09%
18,000
+3,000
+20% +$942K
2024 Q2
9 quarters
A icon
15
Agilent Technologies
A
$48.8B
$5.17M 2.95%
30,000
– –
2024 Q4
7 quarters
CNC icon
16
Centene
CNC
$37B
$4.97M 2.84%
+80,000
New +$5.22M
2026 Q3
0 quarters
LLY icon
17
Eli Lilly
LLY
$1.28T
$4.89M 2.8%
4,230
-770
-15% -$909K
2021 Q2
21 quarters
EHC icon
18
Encompass Health
EHC
$13.9B
$4.86M 2.78%
40,000
+25,000
+167% +$2.94M
2020 Q3
24 quarters
RVTY icon
19
Revvity
RVTY
$16.6B
$4.59M 2.62%
+30,000
New +$3.69M
2026 Q3
0 quarters
WAT icon
20
Waters
WAT
$89.1B
$4.39M 2.51%
10,000
-5,000
-33% -$2M
2026 Q1
2 quarters
BRKR icon
21
Bruker
BRKR
$9.26B
$4.21M 2.4%
+65,000
New +$3.83M
2026 Q3
0 quarters
EW icon
22
Edwards Lifesciences
EW
$61.6B
$3.88M 2.22%
45,000
+25,000
+125% +$2.22M
2025 Q4
3 quarters
MDT icon
23
Medtronic
MDT
$132B
$3.88M 2.22%
+45,000
New +$3.97M
2026 Q3
0 quarters
RGEN icon
24
Repligen
RGEN
$10.4B
$3.84M 2.2%
+20,000
New +$3.25M
2026 Q3
0 quarters
MTD icon
25
Mettler-Toledo International
MTD
$34.4B
$3.78M 2.16%
2,500
-250
-9% -$345K
2025 Q4
3 quarters

Similar funds

Sivik Global Healthcare's Q3 2026 Portfolio in Review

As of Q3 2026, Sivik Global Healthcare held 46 positions worth $175M, up 33% from $132M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Sivik Global Healthcare deployed $23.3M of net new capital in Q3 2026, opening 12 new positions and adding to 14 existing holdings. Its largest new stake was Centene: 80,000 shares worth $4.97M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 82% a quarter earlier, followed by Miscellaneous.

On the sell side, the largest reduction was Waters, an estimated $2M trimmed.

  • Sivik Global Healthcare's largest Q3 2026 buy was Centene: 80,000 shares worth $4.97M.
  • Sivik Global Healthcare added most to State Street SPDR S&P Biotech ETF in Q3 2026, an estimated $4.74M increase.
  • Sivik Global Healthcare's biggest Q3 2026 reduction was Waters, cutting an estimated $2M.
  • Sivik Global Healthcare fully exited Intuitive Surgical in Q3 2026, selling an estimated $4.15M.
  • Sivik Global Healthcare's ten largest holdings make up 46% of its $175M portfolio in Q3 2026.
  • Sivik Global Healthcare opened 12 new positions and closed 11 in Q3 2026.
  • Sivik Global Healthcare's portfolio value rose 33% quarter-over-quarter to $175M.

Based on Sivik Global Healthcare's 13F filing for Q3 2026, filed 13 Oct 2026.